Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), bought 13,358 shares at $1.93 ($25K) on 2022-12-09, disclosed to the SEC on 2022-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.69 | 3,000 | $5K | 20.2% |
| 2 | $1.93 | 10,358 | $20K | 79.8% |
| Total | $1.88 avg | 13,358 | $25K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $552K | — | Filing → |
| CADL | SELL | 2025-01-17 | $207K | — | Filing → |
| CADL | SELL | 2025-01-10 | $239K | — | Filing → |